GermlineCDKN2AMutation Status and Survival in Familial Melanoma Cases
- 10 June 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 108 (11) , djw135
Abstract
Background: Germline mutations in CDKN2A have been associated with increased risk of melanoma and tobacco-related cancers in respiratory and upper digestive tissues. In CDKN2A wild-type (wt) melanoma families, other known high-risk, melanoma-predisposing mutations are rare, and no increased risk has been observed for nonskin cancers in this group. This study is the first to compare survival in germline CDKN2A mutated (mut) and nonmutated melanoma cases.Keywords
This publication has 40 references indexed in Scilit:
- CDKN2a mutation‐negative melanoma families have increased risk exclusively for skin cancers but not for other malignanciesInternational Journal of Cancer, 2015
- Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variantEuropean Journal of Human Genetics, 2014
- High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma familiesJournal of Medical Genetics, 2014
- Risk of Non-Melanoma Cancers in First-Degree Relatives of CDKN2A Mutation CarriersJNCI: Journal of the National Cancer Institute, 2012
- Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL StudyJNCI: Journal of the National Cancer Institute, 2010
- Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma FamiliesClinical Cancer Research, 2008
- Geographical Variation in the Penetrance of CDKN2A Mutations for MelanomaJNCI: Journal of the National Cancer Institute, 2002
- Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden)International Journal of Cancer, 2000
- High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma FamiliesJNCI: Journal of the National Cancer Institute, 2000
- Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4MutationsNew England Journal of Medicine, 1995